Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle Invasive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02203136
What this trial is testing

Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 16
Not applicableStudy completedNCT04319263
What this trial is testing

Oncological Outcomes of Different Patterns of Tumor Recurrence at First Evaluation After Bacillus Calmette-Guérin Induction Therapy for Intermediate and High Risk Non Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Mansoura University 1,600
Testing effectiveness (Phase 2)Looking for participantsNCT04106115
What this trial is testing

DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr

Who this might be right for
Bladder Cancer
University College, London 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07827612
What this trial is testing

Vepugratinib (LY3866288) in Adults With Non-Muscle Invasive Bladder Cancer and Upper Tract Urothelial Cancer

Who this might be right for
Urinary Bladder NeoplasmsUrologic NeoplasmsReceptor, Fibroblast Growth Factor, Type 3
Eli Lilly and Company 161
Not applicableStudy completedNCT01224665
What this trial is testing

S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
SWOG Cancer Research Network 658
Testing effectiveness (Phase 2)Active Not RecruitingNCT06133517
What this trial is testing

PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive blAdder Cancer

Who this might be right for
Urothelial Bladder Carcinoma
Fundación para el Progreso de la Oncología en Cantabria 70
Not applicableNot Yet RecruitingNCT07525349
What this trial is testing

Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder CarcinomaUrothelial Carcinoma (UC)Bladder Cancer+2 more
Assiut University 100
Not applicableWithdrawnNCT04717817
What this trial is testing

Inspiratory Muscle Training Prior to Conventional and Minimal Invasive Heart Surgery

Who this might be right for
Coronary Artery Bypass Graft SurgeryValve ReplacementPost-Op Complications+1 more
Universitair Ziekenhuis Brussel
Testing effectiveness (Phase 2)Study completedNCT01731652
What this trial is testing

Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer

Who this might be right for
Carcinoma in SituNon Muscle Invasive Bladder Cancer
Telormedix SA 12
Not applicableLooking for participantsNCT06341478
What this trial is testing

Investigator Grant (IG) 2022 27746

Who this might be right for
Bladder Cancer
IRCCS San Raffaele 153
Not applicableWithdrawnNCT00084578
What this trial is testing

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Who this might be right for
Bladder Cancer
Fox Chase Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT03799835
What this trial is testing

Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients

Who this might be right for
Bladder Cancer
UNICANCER 517
Testing effectiveness (Phase 2)UnknownNCT05445648
What this trial is testing

Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 65
Testing effectiveness (Phase 2)Looking for participantsNCT07717242
What this trial is testing

Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer

Who this might be right for
Bladder Urothelial CarcinomaBladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT06187506
What this trial is testing

Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerHER-2 Protein Overexpression
Fudan University 20
Not applicableStudy completedNCT00735384
What this trial is testing

Muscle Force Assessment in the Intensive Care Unit and in Primary Myopathies

Who this might be right for
SepsisPrimary Myopathies
University Hospital, Basel, Switzerland 22
Large-scale testing (Phase 3)UnknownNCT05392634
What this trial is testing

Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery

Who this might be right for
Bladder Cancer
N.N. Petrov National Medical Research Center of Oncology 98
Not applicableStudy completedNCT05324033
What this trial is testing

Sensitivity of Multiparametric MRI in Differentiation Between Muscle Invasive and Non-muscle Invasive Urinary Bladder Cancer

Who this might be right for
Cancer, Bladder
Helwan University 30
Not applicableStudy completedNCT00582387
What this trial is testing

Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerUrinary CancerNonmuscle Invasive Bladder Cancer
Memorial Sloan Kettering Cancer Center 116
Early research (Phase 1)Study completedNCT02311101
What this trial is testing

Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasm
The University of Texas Health Science Center at San Antonio 18
Next Page